In 2005 the Riverside Company, a private equity firm acquired Diatron MI PLC, a manufacturer of hematology analyzers as their first step in building a global IVD company. Their vision is to establish Diatron as an industry leading manufacturer supplying small and medium sized laboratories with a complete range of diagnostic instrumentation and reagents.
In staying true to their vision, Riverside then acquired Reagent Ltd. in 2007 to build the company's own reagent manufacturing facility. Upon that acquisition, Diatron propelled themselves to the enviable and necessary position of being able to offer their customers complete hematolgy sytems for the first time.
In 2008, Diatrons purchase UV-Vis Metrolab S.A., an Argentinean manufacturer of automated clinical chemistry analyzers, represented another major milestone towards completing the company's vision. Due to Diatron's continuous growth, from 2013 Diatron is responsible for manufacturing all automated clinical chemistry analyzers.
Diatrons objective to complete their vision is evident by their commitment to funding thier own research and development. In addition, Diatron continues their search for new companys to acquire that compliment their current product offerings. Consequently, completing their vision as a worldwide leading IVD company providing their customers with high-quality products and wider product portfolio.